Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between genetic polymorphisms in fibrinogen genes and bleeding risk in patients treated with direct oral anticoagulants.

Annals of the Academy of Medicine, Singapore - 28 Jul 2023

Choi Kyung Hee, Yee Jeong, Song Tae-Jin, Park Junbeom, Gwak Hye Sun

Abstract excerpt

Introduction: This study aimed to investigate the association between polymorphisms in fibrinogen genes and bleeding risk in patients receiving direct oral anticoagulants (DOACs). Method: Patients treated with DOACs from June 2018 to December 2021 were enrolled in the study. Genotyping was done for rs2070011, rs6050, and rs2070022 in fibrinogen alpha chain (FGA); rs1800788, rs4220, and in fibrinogen...

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Oral
Share to Aged
Share to Aged, 80 and over
Share to Anemia
Share to Anticoagulants
Share to Fibrinogen
Share to Hemorrhage
Share to Risk Factors

Source

Identifiers

PMID: 38904499
DOI: 10.47102/annals-acadmedsg.202328

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between genetic polymorphisms in fibrinogen genes and bleeding risk in patients treated with direct oral anticoagulants.PMID 38904499Read ↗

Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral AnticoagulantsSemantic proximity Read ↗

ABCG2 Gene Polymorphisms May Affect the Bleeding Risk in Patients on Apixaban and Rivaroxaban.Semantic proximity Read ↗

Effect of Genotype on the Pharmacokinetics and Bleeding Events of Direct Oral Anticoagulants: A Systematic Review and Meta-analysis.Semantic proximity Read ↗

Association of Genetic Variants With Rivaroxaban Pharmacokinetics and Pharmacodynamics and Hemorrhage Risk Factors in Patients With Venous Thromboembolism.Semantic proximity Read ↗

Mutations in inherited fibrinogen disorders correlated with clinical features in the Chinese population.Semantic proximity Read ↗

Pharmacogenetics of Bleeding and Thromboembolic Events in Direct Oral Anticoagulant Users.Semantic proximity Read ↗

Effect of gene polymorphism on bleeding complications in Chinese Han patients taking warfarin.Semantic proximity Read ↗

Genetic assessment of efficacy and safety profiles of coagulation cascade proteins identifies Factors II and XI as actionable anticoagulant targetsSemantic proximity Read ↗

Exome-Wide Association Study of candidate pharmacogenes on DOAC haemorrhageSemantic proximity Read ↗

Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.Semantic proximity Read ↗

Fibrinogen Bonn (p. Arg510Cys) in the Aα-Chain Is Associated with High Risk of Venous Thrombosis.Semantic proximity Read ↗

Efficacy and safety of genotype-guided warfarin dosing versus non-genotype-guided warfarin dosing strategies: A systematic review and meta-analysis of 27 randomized controlled trials.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.